Proceeds from the Series B financing will be used to fund the completion of enrollment in the CRESTONE study and other corporate development activities.

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

888 7th Ave. 12th Floor
New York, NY 10106
USA

Phone

(716) 371-1125

Website

www.elevationoncology.com

Email Address

[email protected]

Overview

Elevation Oncology is founded on the belief that every patient with cancer deserves to know what is driving the growth of their disease and have access to therapeutics that can stop it. We make genomic tests actionable by selectively developing drugs to inhibit the specific alterations that have been identified as drivers of disease.

Profile

Social Media

Elevation Oncology Company Twitter Account

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Steve Elms

Chief Executive Officer

Shawn Leland

Vice President

Douglas Plessinger

Vice President

Siera Talbott

VP - Regulatory Affairs

Amy Cavers

VP - Regulatory Affairs

Sheila Magil

Browse more venture capital transactions:

Prev: 11/19/2020: build.security venture capital transaction
Next: 11/19/2020: NestEgg venture capital transaction

Share this article

About Database of VC Transactions

We do our best to report on all VC transactions involving tech companies. All VC database entries reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary